相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain
Fadi Rofo et al.
THERANOSTICS (2021)
Passive antiamyloid immunotherapy for Alzheimer's disease
Julia C. Loureiro et al.
CURRENT OPINION IN PSYCHIATRY (2020)
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval
Martin Tolar et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer's disease
Tobias Gustavsson et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Toxic amyloid-β oligomers induced self-replication in astrocytes triggering neuronal injury
Wei Wang et al.
EBIOMEDICINE (2019)
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms
Suman De et al.
NATURE COMMUNICATIONS (2019)
Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications
Yannick Chantran et al.
FRONTIERS IN IMMUNOLOGY (2019)
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
Christopher H. van Dyck
BIOLOGICAL PSYCHIATRY (2018)
Alzheimer's Disease: Advances in Drug Development
Morgane Piton et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Greta Hultqvist et al.
THERANOSTICS (2017)
Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis
Jia-Jie Mo et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
Xiaotian T. Fang et al.
BIOLOGICAL PROCEDURES ONLINE (2017)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
Dag Sehlin et al.
NATURE COMMUNICATIONS (2016)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains
Thomas J. Esparza et al.
SCIENTIFIC REPORTS (2016)
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
Nishant N. Vaikath et al.
NEUROBIOLOGY OF DISEASE (2015)
In-depth analysis of subclass-specific conformational preferences of IgG antibodies
Xinsheng Tian et al.
IUCRJ (2015)
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-beta Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
Stina Tucker et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
A Generic Method for Design of Oligomer-Specific Antibodies
Kristoffer Brannstrom et al.
PLOS ONE (2014)
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
Kristina Magnusson et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Soluble A ss oligomer production and toxicity
Megan E. Larson et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
Dag Sehlin et al.
PLOS ONE (2012)
Toxic fibrillar oligomers of amyloid-β have cross-β structure
James C. Stroud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties
Thomas Nasstrom et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-A beta Antibodies
Dag Sehlin et al.
NEURODEGENERATIVE DISEASES (2011)
Progressive accumulation of amyloid-β oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins
Emiley Pham et al.
FEBS JOURNAL (2010)
Amyloid-β Oligomer Specificity Mediated by the IgM Isotype - Implications for a Specific Protective Mechanism Exerted by Endogenous Auto-Antibodies
Malin Lindhagen-Persson et al.
PLOS ONE (2010)
Affinity and Avidity in Antibody-Based Tumor Targeting
Stephen I. Rudnick et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Induced Dimerization of the Amyloid Precursor Protein Leads to Decreased Amyloid-β Protein Production
Simone Eggert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
β-Amyloid Monomers Are Neuroprotective
Maria Laura Giuffrida et al.
JOURNAL OF NEUROSCIENCE (2009)
Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity:: Prevention by systemic passive immunization
Igor Klyubin et al.
JOURNAL OF NEUROSCIENCE (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Aβ40 protects non-toxic Aβ42 monomer from aggregation
Yilin Yan et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons
Atul Deshpande et al.
JOURNAL OF NEUROSCIENCE (2006)
Pentamerization of single-domain antibodies from phage libraries: A novel strategy for the rapid generation of high-avidity antibody reagents
JB Zhang et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Development of Aβ terminal end-specific antibodies and sensitive ELISA for Aβ variant
Y Horikoshi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Optimization of codon pair use within the (GGGGS)(3) linker sequence results in enhanced protein expression
R Trinh et al.
MOLECULAR IMMUNOLOGY (2004)
Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
JF Reilly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting
AA Kortt et al.
BIOMOLECULAR ENGINEERING (2001)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
C Nilsberth et al.
NATURE NEUROSCIENCE (2001)
分享论文
